Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02122107 · ClinicalTrials.gov registry record
Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History
A clinical trial of Breast Cancer Survivors, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 499
- Enrollment target
- 2
- Study locations
NCT02122107 is a study of Breast Cancer Survivors that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 499 participants, below the 2,699-participant average among 8 other Breast Cancer Survivors trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02122107, a study of Breast Cancer Survivors, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 499 participants
- Enrollment target
- 2
- Study locations
Study Summary
In this study,the investigators are looking to see how older women who are survivors of breast cancer and either did or did not receive chemotherapy are affected by treatment, compared to older women who have never had cancer. Thinking and memory abilities normally decrease with age and the investigators want to see if the long-term effects of cancer treatments may make these problems worse. The investigators will also look at how thinking and memory abilities of older women are affected by genetics and smoking history. Genetics and other factors may affect the brain's chemicals or structure, and may either protect against the negative effects on thinking or make someone more at risk for them. MSK participants who previously consented to allostatic blood and saliva collection but have not yet provided any allostatic blood or saliva samples for this study, will not be asked to provide any further samples at follow-up. Participants who have consented to allostatic sample collection and provided one set of allostatic blood and saliva samples at a previous follow-up study visit will still be asked to provide a second set of samples at a later follow-up. COH participants will continue to provide allostatic blood and saliva collection as originally outlined
Conditions Studied
Study Locations (2)
California
- City of Hope - Duarte
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 499 participants |
| Start Date | 2014-04-08 |
| Est. Completion | 2027-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02122107
The ClinicalTrials.gov registry entry for NCT02122107 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 499 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,699-participant average among 8 other Breast Cancer Survivors trials with a reported enrollment target (82% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer Survivors appearing as the primary indexed condition, and to 0 interventions.
NCT02122107 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, New York.
Frequently Asked Questions
What is clinical trial NCT02122107 about?
NCT02122107 is a clinical study titled "Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History". In this study,the investigators are looking to see how older women who are survivors of breast cancer and either did or did not receive chemotherapy are affected by treatment, compared to older women who have never had cancer. Thinking and memory abilities normally decrease with age and the investig...
What is the current status of trial NCT02122107?
This trial is currently active not recruiting. The enrollment target is 499 participants. The study started on 2014-04-08. Estimated completion is 2027-04.
What conditions does trial NCT02122107 study?
This clinical trial studies the following conditions: Breast Cancer Survivors.
Who is sponsoring clinical trial NCT02122107?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02122107 being conducted?
This trial has 2 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Survivors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rowing Following Breast Cancer Chemotherapy
RECRUITING · NA
-
UCF MammoChat: Image Repository
RECRUITING
-
A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)
RECRUITING
-
Evaluation of an Online, Remote Cognitive Battery for Use in Cancer Survivorship
ACTIVE NOT RECRUITING
-
Improving Cognition After Cancer
ACTIVE NOT RECRUITING · NA
-
Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.